Body mass index and prognostic markers at radical prostatectomy

References

• Available from: http://www.sst.dk/publ/tidsskrifter/nyetal/pdf/2005/09_05.pdf.
   Google Scholar
• Borre M, Nerstrøm B, Overgaard J. The dilemma of prostate cancer. A growing human and economical burden irrespective of treatment strategies. Acta Oncol 1997; 36: 681–7
   PubMed Web of Science ®Google Scholar
• Available from: http://www.meraadet.dk/gfx/uploads/rapporter_pdf/Fedmerapport_www.pdf.
   Google Scholar
• Bianchini F, Kaaks R, Vainio H. Overweight, obesity, and cancer risk. Lancet Oncol 2002; 3: 565–74
   PubMed Web of Science ®Google Scholar
• Engeland A, Tretli S, Bjørge T. Height, body mass index, and prostate cancer: a follow-up of 950.000 Norwegian men. Br J Cancer 2003; 89: 1237–42
   PubMed Web of Science ®Google Scholar
• Freedland SJ, Terris MK, Platz EA, Presti JC. Body mass index as a predictor of prostate cancer: development versus detection on biopsy. Urology 2005; 66: 108–13
   PubMed Web of Science ®Google Scholar
• Schuurman AG, Goldbohm RA, Dorant E, Brandt PA. Anthropometry in relation to prostate cancer risk in the Netherlands Cohort Study. Am J Epidemiol 2000; 151: 541–9
   PubMed Web of Science ®Google Scholar
• Available from: www.who.int/bmi.
   Google Scholar
• Smith MR. Obesity and sex steroids during gonadotropin-releasing hormone agonist treatment for prostate cancer. Clin Cancer Res 2007; 13: 241–5
   PubMed Web of Science ®Google Scholar
• Vermeulen A, Kaufmann JM, Giagulli VA. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males. J Clin Endocrinol Metab 1996; 81: 1821–6
   PubMed Web of Science ®Google Scholar
• Hammarsten J, Hogstedt B. Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia. Eur Urol 2001; 39: 151–8
   PubMed Web of Science ®Google Scholar
• Rodriguez C, Freedland SJ, Deka A, Jacobs EJ, McCullough ML, Patel AV, et al. Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev 2007; 16: 63–9
   PubMed Web of Science ®Google Scholar
• Wright ME, Chang S-C, Schatzkin A, Albanes D, Kipnes V, Mouw T, et al. Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality. Cancer 2007; 109: 675–84
   PubMed Web of Science ®Google Scholar
• Baillargeon J, Pollock BH, Kristal A, Bardshaw P, Hernandez J, Basler B, et al. The association of body mass index and prostate-specific antigen in a population-based study. Cancer 2005; 103: 1092–5
   PubMed Web of Science ®Google Scholar
• Freedland SJ, Platz EA, Presti JC, Jr, Aronson WJ, Amling CL, Kane CJ, et al. Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection. J Urol 2006; 175: 500–4
   PubMedGoogle Scholar
• Amling CL, Kane CJ, Riffenburgh RH, Ward JF, Roberts JL, Lance RS, et al. Relationship between obesity and race in predicting adverse pathologic variables in patients undergoing radical prostatectomy. Urology 2001; 58: 723–8
   PubMed Web of Science ®Google Scholar
• Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Willett WC. Height, body weight, and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 1997; 6: 557–63
   PubMed Web of Science ®Google Scholar
• Andersson S, Wolk A, Bergstrom R, Adami H, Engholm G, Englund A, et al. Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers. J Natl Cancer Inst 1997; 89: 385–9
   PubMed Web of Science ®Google Scholar
• Gallina A, Karakiewicz PI, Hutterer GC, Chun FKH, Briganti A, Walz J, et al. Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical prostatectomy in European men. Int J Cancer 2007; 121: 791–5
   PubMed Web of Science ®Google Scholar
• Amling CL, Riffenburgh RH, Sun L, Moul JW, Lance RS, Kusuda L, et al. Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy. J Clin Oncol 2004; 22: 439–45
   PubMed Web of Science ®Google Scholar
• Freedland SJ, Aronson WJ, Kane CJ, Presti JC, Jr, Amling CL, Elashoff D, et al. Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group. J Clin Oncol 2004; 22: 446–53
   PubMed Web of Science ®Google Scholar
• Bassett WW, Cooperberg MR, Sadetsky N, Silva S, Duchane J, Pasta GJ, et al. Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE. Urology 2005; 66: 1060–5
   PubMed Web of Science ®Google Scholar
• Siddiqui SA, Inman BA, Sengupta S, Slezak JM, Bergstralh EJ, Leibovich BC, et al. Obesity and survival after radical prostatectomy. A 10-year prospective cohort study. Cancer 2006; 107: 521–9
   PubMed Web of Science ®Google Scholar
• Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults. JAMA 2002; 288: 1723–7
   PubMed Web of Science ®Google Scholar